The liquid biopsy performed at the time of immunohistochemical non-small cell lung cancer diagnosis revealed within 7 days the presence of an epidermal growth factor receptor (<i>EGFR)</i> <sup>DEL19</sup> activating mutation with 736,400 DNA copies/ml of plasma. Here, EGFR is linked to non-small cell lung carcinoma.